Loading organizations...
§ Private Profile · Bengaluru, Karnataka
Sugar.fit is a technology company.
Sugar.fit provides a holistic diabetes and obesity management program, integrating continuous glucose monitoring (CGM) for real-time blood sugar tracking. It combines this technology with personalized coaching from expert diabetologists, endocrinologists, and dieticians. This approach delivers data-backed insights and tailored interventions, guiding users toward improved metabolic health and sustainable lifestyle changes.
Madan Somasundaram and Shivtosh Kumar co-founded Sugar.fit in 2021. Their insight stemmed from a critical need for an integrated, technology-enabled solution for chronic disease management, especially diabetes. Leveraging their experience in scaling technology ventures, they established the company to merge medical expertise with innovative digital health tools.
The company primarily serves individuals actively managing or seeking to reverse diabetes and address obesity. Sugar.fit's overarching vision is to empower its community with comprehensive programs and continuous support. It aims to redefine chronic condition management by focusing on lasting behavioral shifts and data-informed strategies to achieve enduring health outcomes.
Sugar.fit has raised $26.0M across 3 funding rounds.
Sugar.fit has raised $26.0M in total across 3 funding rounds.
Sugar.fit has raised $26.0M across 3 funding rounds. Most recently, it raised $5.0M Series A in March 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2024 | $5M Series A | B Capital Group | MassMutual Ventures, Adrian Aoun, Kunal Shah, Cure.fit, Endiya Partners, Tanglin Venture Partners | Announced |
| Oct 1, 2023 | $11M Series A | MassMutual Ventures | Lightspeed India Partners, Cure.fit, Endiya Partners, Tanglin Venture Partners | Announced |
| Sep 3, 2021 | $10M Seed | — | Cure.fit, DR. Ramesh Byrapaneni, Tanglin Venture Partners | Announced |
Sugar.fit has raised $26.0M in total across 3 funding rounds.
Sugar.fit's investors include B Capital Group, MassMutual Ventures, Adrian Aoun, Kunal Shah, Cure.fit, Endiya Partners, Tanglin Venture Partners, Lightspeed India Partners, Dr. Ramesh Byrapaneni.
Sugar.fit is a Bengaluru-based healthtech startup founded in 2021, specializing in tech-enabled diabetes management and reversal for type 2 diabetes and prediabetes patients.[2][3][4] It offers a comprehensive subscription-based program integrating continuous glucose monitoring (CGM) devices, a mobile app for real-time tracking, personalized nutrition and fitness plans, unlimited expert consultations with doctors and coaches, and comprehensive health testing, priced at around ₹15,990 to ₹29,990 with no-cost EMI options.[1][4][5] Serving primarily individuals in India struggling with lifestyle-driven diabetes, Sugar.fit solves the challenges of restrictive, stressful traditional treatments by providing sustainable, habit-based guidance that tracks lifestyle impacts on glucose levels, leading to outcomes like an average 1.9% HbA1c drop, 90% of users reducing/eliminating medication, 92% cutting insulin use, and sustained 3+ kg weight loss in three months.[1][4] With 227 employees, over ₹206 Cr ($26M) in funding across Series A rounds from investors like Curefit Healthcare, MassMutual Ventures, Tanglin Venture Partners, and B Capital, and 60,000+ users, the company shows strong growth momentum, including physical clinics in Bangalore and a digital store for diabetic-friendly foods.[2][3][4][5]
Sugar.fit was founded in 2021 in Bengaluru, India, amid rising diabetes prevalence driven by lifestyle factors, with founders drawing on expertise in healthtech to create a non-restrictive reversal program.[2][3][4] The idea emerged from recognizing gaps in India's diabetes care—high non-adherence due to complex regimens and lack of real-time insights—leading to a platform blending innovative CGM tech, AI-driven recommendations, and human coaching from endocrinologists.[1][4] Early traction came quickly through a product-first approach, achieving clinical validations like 90% HbA1c reductions in high-risk users within 90 days, presentations at the American Diabetes Association's 82nd Session (2022) and Diacare conference, and rapid scaling to leadership in digital diabetes management.[1][4]
Sugar.fit stands out in diabetes care through its full-stack, personalized model combining tech and human elements:
These features create a seamless developer-like experience for users, fostering high retention (4.9+ Google rating).[5]
Sugar.fit rides the wave of India's exploding diabetes epidemic—over 100 million cases, fueled by urbanization and poor lifestyles—timing perfectly with CGM affordability and AI healthtech maturation.[4] Market forces like rising healthcare costs, post-pandemic digital adoption, and insurer demand for preventive care favor its model, which reduces medication dependency and complications, influencing ecosystems by validating hybrid (tech + human) chronic care in emerging markets.[1][3][4] As a leader among Indian peers like Life in Control, it pushes healthtech toward outcome-based platforms, partnering with corporates and potentially health plans, while expanding clinics signals a hybrid future blending telehealth with physical touchpoints.[3][4]
Sugar.fit is poised for hypergrowth by scaling clinics nationwide, deepening e-commerce for nutrition, and leveraging funding for AI enhancements and insurer tie-ups, potentially capturing a slice of India's $10B+ diabetes market.[2][4] Trends like wearable integration, personalized medicine via AI, and government pushes for non-communicable disease control will propel it, evolving from digital-first to a full ecosystem player influencing policy and global healthtech exports. With 60,000+ users and clinic momentum, expect IPO readiness in 2-3 years, redefining diabetes from chronic burden to reversible condition through sustained innovation.[5] This positions Sugar.fit as a blueprint for tech-driven health transformation in high-burden regions.